| Literature DB >> 24623580 |
Francesca Bugli1, Francesco Paroni Sterbini, Margherita Cacaci, Cecilia Martini, Stefano Lancellotti, Egidio Stigliano, Riccardo Torelli, Vincenzo Arena, Morena Caira, Patrizia Posteraro, Maurizio Sanguinetti, Brunella Posteraro.
Abstract
Gliotoxin (GT) belongs to the epipolythiodioxopiperazine class of toxins secreted from certain fungi including Aspergillus fumigatus, which is the most prolific producer of this secondary metabolite. Recently, enhanced amounts of GT were found in in vitro biofilm-grown A. fumigatus mycelium. To further correlate the A. fumigatus biofilm growth phenotype with the enhanced secretion of GT, a polyclonal antibody (pAb) was produced by immunizing mice against GT. By an indirect immunofluorescent assay, pAb was then able to recognize specifically GT onto A. fumigatus Af293 biofilm formed on human pulmonary epithelial cells. Then, treating Af293 biofilms with a compound which reduces the GT disulfide bonds provoked shutdown of the GT-specific immunofluorescence (IF) signals along the hyphae. To explore the potential of GT for diagnostic use, pAb was shown to react with GT on hyphae into Aspergillus culture-positive respiratory tract specimens from patients with probable invasive aspergillosis (IA) and into tissue specimens from the lungs of patients with proven IA. As the presence of fungal hyphae in clinical specimens strongly indicates the in vivo A. fumigatus growth as a biofilm, anti-GT antibodies could be a specific and sensitive diagnostic tool for detecting A. fumigatus biofilm-associated clinical infections.Entities:
Keywords: Aspergillus fumigatus; biofilm; fungal biofilm-associated infection; gliotoxin; immunofluorescent assay
Mesh:
Substances:
Year: 2014 PMID: 24623580 DOI: 10.1111/2049-632X.12152
Source DB: PubMed Journal: Pathog Dis ISSN: 2049-632X Impact factor: 3.166